Study for adults with lung nodules on CT
Part of Cancer, Lungs & breathing clinical trials.
This study follows adults who have a lung nodule seen on a CT scan that looks more concerning based on lung screening scoring. It may help doctors understand which nodules are most likely to be cancer and how to track them safely over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have one or more lung nodules seen on a chest CT scan
- Your nodule must meet lung screening risk criteria, such as Lung-RADS 4A or higher
- Alternatively, your nodule must have a lung cancer risk of 5% or higher using the Brock risk estimate
- You should not already have proven (confirmed) lung cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
This study looks at whether a new test can better identify early lung cancer in people who are being watched for an incidental lung nodule. It may help doctors decide which nodules need closer follow-up or treatment.
This trial uses a new, non-invasive way to screen for lung cancer by combining your breath, blood, and CT scan images. The goal is to figure out whether a nodule found on a CT scan is cancerous or not, which could help patients avoid unnecessary procedures.
This trial tests a new nasal swab test to help doctors better understand your risk if you have a small lung nodule. The test looks at cells from your nose to give more information about whether the nodule might be cancer, without needing a biopsy right away.
This study looks at whether MRI scans and blood-related biomarkers can help better understand lung nodules found during routine lung cancer screening. It may help doctors decide which nodules need closer follow-up versus less intensive monitoring.
This study tests whether Optellum’s AI prediction tool can better identify which lung nodules found on CT scans are more likely to be cancer. You may be asked to provide specific types of CT images so the tool can be evaluated.
Hear when a new Pulmonary Nodule, Solitary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.